Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks

详细信息    查看全文

• 作者：Huizhen Sun^a ; ^b ; ¹ ; Yan Wang^a ; ^b ; ¹ ; Ziliang Wang^a ; ^b ; Jiao Meng^a ; ^b ; Zihao Qi^a ; ^b ; Gong Yang^a ; ^b ; ^c ; ^{yanggong@fudan.edu.cn" class="auth_mail}
• 关键词：Aur-A ; Aurora-A cDNA-infected cells ; Aur-Ai ; Aurora-A shRNA-infected cells ; BRCA1i ; BRCA1 shRNA-infected cells ; BRCA2i ; BRCA2 shRNA-infected cells ; Scr ; scrambled shRNA-infected cells ; IR ; Irradiation ; Cis ; Cisplatin ; KU ; KU-55933 ; the inhibitor of ATM
• 刊名：Biochimica et Biophysica Acta (BBA)/Molecular Cell Research
• 出版年：May, 2014
• 年：2014
• 卷：1843
• 期：5
• 页码：934-944
• 全文大小：2053 K

文摘

High expression of Aurora kinase A (Aurora-A) has been found to confer cancer cell radio- and chemoresistance, however, the underlying mechanism is unclear. In this study, by using Aurora-A cDNA/shRNA or the specific inhibitor VX680, we show that Aurora-A upregulates cell proliferation, cell cycle progression, and anchorage-independent growth to enhance cell resistance to cisplatin and X-ray irradiation through dysregulation of DNA damage repair networks. Mechanistic studies showed that Aurora-A promoted the expression of ATM/Chk2, but suppressed the expression of BRCA1/2, ATR/Chk1, p53, pp53 (Ser15), H2AX, 纬H2AX (Ser319), and RAD51. Aurora-A inhibited the focus formation of 纬H2AX in response to ionizing irradiation. Treatment of cells overexpressing Aurora-A and ATM/Chk2 with the ATM specific inhibitor KU-55933 increased the cell sensitivity to cisplatin and irradiation through increasing the phosphorylation of p53 at Ser15 and inhibiting the expression of Chk2, 纬H2AX (Ser319), and RAD51. Further study revealed that BRCA1/2 counteracted the function of Aurora-A to suppress the expression of ATM/Chk2, but to activate the expression of ATR/Chk1, pp53, 纬H2AX, and RAD51, leading to the enhanced cell sensitivity to irradiation and cisplatin, which was also supported by the results from animal assays. Thus, our data provide strong evidences that Aurora-A and BRCA1/2 inversely control the sensitivity of cancer cells to radio- and chemotherapy through the ATM/Chk2-mediated DNA repair networks, indicating that the DNA repair molecules including ATM/Chk2 may be considered for the targeted therapy against cancers with overexpression of Aurora-A.